Renal aspects of treatment with conventional nonsteroidal anti-inflammatory drugs versus cyclooxygenase-2–specific inhibitors
- 1 February 2001
- journal article
- research article
- Published by Elsevier in The American Journal of Medicine
- Vol. 110 (3) , 33-42
- https://doi.org/10.1016/s0002-9343(00)00699-9
Abstract
No abstract availableThis publication has 48 references indexed in Scilit:
- Nephrotoxicity of nonsteroidal anti-inflammatory drugs: physiologic foundations and clinical implicationsThe American Journal of Medicine, 1999
- Cyclooxygenase in biology and diseaseThe FASEB Journal, 1998
- Cyclooxygenase-1 and Cyclooxygenase-2 Selectivity of Widely Used Nonsteroidal Anti-Inflammatory DrugsThe American Journal of Medicine, 1998
- Nonsteroidal Anti‐Inflammatory Drugs: Effects on Kidney FunctionThe Journal of Clinical Pharmacology, 1991
- Clinical Implications of Prostaglandin and Thromboxane A2FormationNew England Journal of Medicine, 1988
- Clinical Implications of Prostaglandin and Thromboxane A2FormationNew England Journal of Medicine, 1988
- Ibuprofen-Induced Acute Renal Failure with Acute Tubular NecrosisAmerican Journal of Nephrology, 1982
- Irreversible Renal Failure after Indomethacin in Steroid-Resistant NephrosisNew England Journal of Medicine, 1980
- Acute Oliguric Renal Failure Induced by Indomethacin: Possible MechanismAnnals of Internal Medicine, 1979
- The Effect of Indomethacin on Proteinuria and Kidney Function in the Nephrotic SyndromeActa Medica Scandinavica, 1976